A phase I pharmacokinetic study of erlotinib administration in combination with amrubicin in patients with previously treated, advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update:
06 Dec 2015
Note:
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.